Mendillo Jane L — SEC Form 4 filings

SEC reporting owner CIK 1672424. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-02.

Transaction summary — filings shown

Covers all 7 filings on record, filed 2024-02-16 to 2026-03-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Generate Biomedicines, Inc. (GENB)Director11 leg · 1,500 sh · $24,0001
Lazard, Inc. (LAZ)Director66

Form 4 filings — Mendillo Jane L

FiledFormIssuerReported transactionsSource
2026-03-024Generate Biomedicines, Inc. (GENB)Purchase (P): 1,500 @ $16 · Grant/award (A): 29,561 (derivative) @ $0EDGAR
2025-02-204Lazard, Inc. (LAZ)Grant/award (A): 642 (derivative) @ $0EDGAR
2024-11-194Lazard, Inc. (LAZ)Grant/award (A): 636 (derivative) @ $0EDGAR
2024-08-194Lazard, Inc. (LAZ)Grant/award (A): 766 (derivative) @ $0EDGAR
2024-06-054Lazard, Inc. (LAZ)Grant/award (A): 4,307 (derivative) @ $0EDGAR
2024-05-154Lazard, Inc. (LAZ)Grant/award (A): 899 (derivative) @ $0EDGAR
2024-02-164Lazard, Inc. (LAZ)Grant/award (A): 953 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1672424 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →